Aytu BioPharma: Q3 Earnings Insights

Aytu BioPharma AYTU reported its Q3 earnings results on Monday, May 16, 2022 at 04:02 PM.

Here's what investors need to know about the announcement.

Earnings

Aytu BioPharma beat estimated earnings by 34.15%, reporting an EPS of $-0.27 versus an estimate of $-0.41.

Revenue was up $10.72 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.14 which was followed by a 7.26% increase in the share price the next day.

Here's a look at Aytu BioPharma's past performance:

To track all earnings releases for Aytu BioPharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.